glp 1 agonists addiction GLP-1 receptor show promise in treating substance use disorders IUPHAR review – Glucagon-like peptide-1

This review examines the biological mechanisms underlying GLP-1 RA therapy in MASLD/MASH, analyzes the mechanistic distinctions between mono-, dual-, and triple agonists, and synthesizes current clinical evidence supporting their utilization in individuals with this condition.

Moreover, in collaboration with the CNRS (National Center for Scientific Research), we have developed a specific analytical method based on stable isotope measurement

Oral GLP-1 RA are also under development and early data shows similar WL efficacy to semaglutide 2.4mg

Does GLP-1 help with Hashimoto's disease

Clostridium butyricum produces the postbiotic butyrate which stimulates GLP-1. Bifidobacterium infantis produces the postbiotic acetate, and interacts with Akkermansia and Butyricum to promote an ecosystem in the gut that naturally boosts GLP-1